BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8635492)

  • 21. Characterization of retinoic acid-induced AP-1 activity in B16 mouse melanoma cells.
    Desai SH; Niles RM
    J Biol Chem; 1997 May; 272(19):12809-15. PubMed ID: 9139741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and analysis of melanoma cell mutants resistant to the antiproliferative action of retinoic acid.
    Lotan R; Stolarsky T; Lotan D
    Cancer Res; 1983 Jun; 43(6):2868-75. PubMed ID: 6850598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of retinoic acid-enhanced sialyltransferase activity and glycosylation of specific cell surface sialoglycoproteins with growth inhibition in a murine melanoma cell system.
    Lotan R; Lotan D; Meromsky L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5805-12. PubMed ID: 6498840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
    Lotan R
    Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
    Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R
    Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY; Repasky E; Liu HT
    Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
    Mira-y-Lopez R
    J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different response to retinoic acid of two teratocarcinoma cell lines.
    Wan YJ; Wang L; Wu TC
    Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
    Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
    Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells.
    Rosenbaum SE; Niles RM
    Arch Biochem Biophys; 1992 Apr; 294(1):123-9. PubMed ID: 1550338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and regulation of retinoid X receptors in B16 melanoma cells.
    Desai DS; Niles RM
    J Cell Physiol; 1995 Nov; 165(2):349-57. PubMed ID: 7593213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of melanotic expression in cultured mouse melanoma cells by retinoids.
    Lotan R; Lotan D
    J Cell Physiol; 1981 Feb; 106(2):179-89. PubMed ID: 6260817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
    Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
    Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-box binding protein type two (TBX2) is an immediate early gene target in retinoic-acid-treated B16 murine melanoma cells.
    Boskovic G; Niles RM
    Exp Cell Res; 2004 May; 295(2):281-9. PubMed ID: 15093729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
    Abemayor E
    Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation.
    Gruber JR; Ohno S; Niles RM
    J Biol Chem; 1992 Jul; 267(19):13356-60. PubMed ID: 1618838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
    Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
    J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative switch in integrin expression accompanies differentiation of F9 cells treated with retinoic acid.
    Burdsal CA; Lotz MM; Miller J; McClay DR
    Dev Dyn; 1994 Dec; 201(4):344-53. PubMed ID: 7894073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin. A potential pathway for cyclic AMP regulation of retinoid action.
    Desai D; Michalak M; Singh NK; Niles RM
    J Biol Chem; 1996 Jun; 271(25):15153-9. PubMed ID: 8662962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.